Clinical Trials Directory

Trials / Completed

CompletedNCT05070949

Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

This study explored the effects of self-compassion intervention on diabetes distress and self-compassion.

Detailed description

This study tests the effects of a 12-week mindful self-compassion (MSC) program in people with type 1 diabetes. Eighty participants will be randomized to the MSC program or be in a wait-list control group. Measures of primary outcome are self-compassion and diabetes- distress. Secondary outcomes are hemoglobin A1C, diabetes self-efficacy, stress and depression symptoms, and sleep quality. Outcomes will be measured at baseline, 12 weeks (end of the program) and 24 weeks (post program).

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindful Self-CompassionBi-weekly meeting will involve six lessons: What is Self-Compassion , Practicing Self-Compassion, Discovering your Compassionate Voice, Self-Compassion and Resilience , Self-Compassion and Burnout and Making it Count

Timeline

Start date
2022-01-01
Primary completion
2023-10-10
Completion
2023-11-07
First posted
2021-10-07
Last updated
2025-05-13

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05070949. Inclusion in this directory is not an endorsement.

Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes (NCT05070949) · Clinical Trials Directory